Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-6-3
pubmed:abstractText
Modeling, synthesis and in vitro activities of a series of arylaminoethyl amide based inhibitors of the cysteine protease cathepsin K are described.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1997-2001
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
pubmed:affiliation
Arthritis & Bone Metabolism Therapeutic Area, Novartis Pharma AG, CH-4002, Basel, Switzerland, eva.altmann@pharma.novartis.com
pubmed:publicationType
Journal Article